Kenny John P. — SEC insider filings

SEC reporting owner CIK 1719325. 31 insider filings on record with FilingPulse; latest filed 2026-09-09.

Transaction summary — filings shown

Covers all 31 filings on record, filed 2020-11-09 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
MERIDIAN BIOSCIENCE INC (VIVO)Chief Executive Officer, Director, 10% owner14—12 legs · 317,751 sh · $9,138,15833
ORASURE TECHNOLOGIES INC (OSUR)Director91 leg · 47,659 sh · $151,217—8
NEOGENOMICS INC (NEO)Director2——6
Quantum-Si Inc (QSI)Director4——4
BIOMERICA INC (BMRA)Director2——2

Insider filings — Kenny John P.

FiledFormIssuerReported transactionsSource
2026-09-094ORASURE TECHNOLOGIES INC (OSUR)Tax withholding (F): 5,116 @ $3.43EDGAR
2026-06-054ORASURE TECHNOLOGIES INC (OSUR)Grant/award (A): 46,106 @ $0EDGAR
2026-06-034NEOGENOMICS INC (NEO)Option exercise (M): 5,893 @ $0 · Option exercise (M): 5,893 (derivative) @ $0 · Grant/award (A): 11,069 (derivative) @ $0 · Grant/award (A): 15,970 (derivative) @ $0EDGAR
2026-05-204Quantum-Si Inc (QSI)Grant/award (A): 251,185 (derivative) @ $0EDGAR
2026-01-054NEOGENOMICS INC (NEO)Grant/award (A): 4,171 (derivative) @ $0 · Grant/award (A): 5,893 (derivative) @ $0EDGAR
2025-12-194ORASURE TECHNOLOGIES INC (OSUR)Grant/award (A): 10,286 @ $2.46EDGAR
2025-09-264ORASURE TECHNOLOGIES INC (OSUR)Grant/award (A): 6,118 @ $3.27EDGAR
2025-06-254ORASURE TECHNOLOGIES INC (OSUR)Grant/award (A): 6,657 @ $3.01EDGAR
2025-05-214Quantum-Si Inc (QSI)Grant/award (A): 126,095 (derivative) @ $0EDGAR
2025-05-154ORASURE TECHNOLOGIES INC (OSUR)Grant/award (A): 71,017 @ $0EDGAR
2025-03-274ORASURE TECHNOLOGIES INC (OSUR)Tax withholding (F): 1,385 @ $3.55EDGAR
2025-02-274ORASURE TECHNOLOGIES INC (OSUR)Purchase (P): 47,659 @ $3.17EDGAR
2024-09-104ORASURE TECHNOLOGIES INC (OSUR)Grant/award (A): 23,256 @ $4.30EDGAR
2024-05-174Quantum-Si Inc (QSI)Grant/award (A): 113,281 (derivative) @ $0EDGAR
2023-12-144BIOMERICA INC (BMRA)Grant/award (A): 75,000 (derivative)EDGAR
2023-12-114BIOMERICA INC (BMRA)Grant/award (A): 30,000 (derivative)EDGAR
2023-05-244Quantum-Si Inc (QSI)Grant/award (A): 114,285 @ $0EDGAR
2023-01-314MERIDIAN BIOSCIENCE INC (VIVO)Grant/award (A): 47,060 · Disposition to issuer (D): 267,651 · Disposition to issuer (D): 66,039 (derivative) @ $23.90 · Disposition to issuer (D): 83,535 (derivative) @ $15.52 · Disposition to issuer (D): 82,940 (derivative) @ $15.12EDGAR
2022-11-084MERIDIAN BIOSCIENCE INC (VIVO)Tax withholding (F): 4,271 @ $32.01EDGAR
2022-10-054MERIDIAN BIOSCIENCE INC (VIVO)Tax withholding (F): 40,269 @ $31.53EDGAR
2022-06-284MERIDIAN BIOSCIENCE INC (VIVO)Option exercise (M): 13,559 @ $10.10 · Sale (S): 13,559 @ $30.00 · Option exercise (M): 61,437 @ $10.10 · Sale (S): 61,437 @ $30.39 · Option exercise (M): 13,559 (derivative) @ $0 · Option exercise (M): 61,437 (derivative) @ $0EDGAR
2022-06-244MERIDIAN BIOSCIENCE INC (VIVO)Option exercise (M): 44,651 @ $14.50 · Sale (S): 44,651 @ $29.72 · Option exercise (M): 5,349 @ $14.50 · Option exercise (M): 14,607 @ $10.10 · Sale (S): 19,956 @ $29.98 · Option exercise (M): 44,651 (derivative) @ $0 · +2 moreEDGAR
2021-11-164MERIDIAN BIOSCIENCE INC (VIVO)Other (J): 155,511 · Grant/award (A): 155,511EDGAR
2021-11-084MERIDIAN BIOSCIENCE INC (VIVO)Grant/award (A): 56,472 @ $0 · Grant/award (A): 82,940 (derivative) @ $0EDGAR
2021-03-184MERIDIAN BIOSCIENCE INC (VIVO)Sale (S): 30,000 @ $25EDGAR
2021-03-114MERIDIAN BIOSCIENCE INC (VIVO)Sale (S): 10,000 @ $25EDGAR
2021-02-174MERIDIAN BIOSCIENCE INC (VIVO)Option exercise (M): 2,082 @ $10.10 · Sale (S): 2,359 @ $30.35 · Option exercise (M): 2,082 (derivative) @ $0EDGAR
2021-02-164MERIDIAN BIOSCIENCE INC (VIVO)Option exercise (M): 1,164 @ $10.10 · Sale (S): 1,320 @ $30.00 · Option exercise (M): 23,097 @ $10.10 · Sale (S): 26,181 @ $30.14 · Option exercise (M): 1,164 (derivative) @ $0 · Option exercise (M): 23,097 (derivative) @ $0EDGAR
2021-02-104MERIDIAN BIOSCIENCE INC (VIVO)Option exercise (M): 50,000 @ $14.50 · Option exercise (M): 16,134 @ $10.10 · Sale (S): 68,288 @ $29.86 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 16,134 (derivative) @ $0EDGAR
2021-02-084MERIDIAN BIOSCIENCE INC (VIVO)Sale (S): 20,000 @ $25 · Sale (S): 20,000 @ $25EDGAR
2020-11-094MERIDIAN BIOSCIENCE INC (VIVO)Grant/award (A): 56,006 @ $0 · Grant/award (A): 83,535 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1719325 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs